Biocodex Acquires Majority Stake in Hilma
November 17, 2022
French pharmaceutical group Biocodex has acquired a majority stake in Hilma, a U.S.-based natural remedies start-up founded by Hilary Quartner, Nina Mullen and Lily Galef. The deal gives Biocodex a stronger foothold in the U.S. digestive-health and women’s-health segments and will help scale Hilma’s omnichannel retail strategy (DTC plus 750+ stores including Target).
- Buyers
- Biocodex Group
- Targets
- Hilma
- Industry
- Pharmaceuticals
- Location
- New York, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
STADA Acquires Biopharma's Pharmaceutical Prescription and Consumer Health Business
December 12, 2019
Pharmaceuticals
The STADA Group agreed to acquire the pharmaceutical prescription and consumer health business of Ukrainian producer Biopharma, including GMP-certified production facilities in Bila Tserkva. The deal integrates Biopharma's pharma operations into STADA's European organization, expands STADA's local production footprint in Ukraine and is subject to Ukrainian merger control; Biopharma's shareholders will retain the company's plasma business.
-
ORIX Corporation USA Acquires Majority Stake in Hilco Global
September 2, 2025
Financial Services
ORIX Corporation USA has completed the acquisition of a majority equity stake in Hilco Global, which will operate as a subsidiary of ORIX USA while Hilco's executive leadership retains a minority ownership position. The transaction reorganizes Hilco into two divisions—Professional Services and Capital Solutions—to expand its valuation, advisory, and asset-based private credit capabilities leveraging ORIX USA's capital and lending expertise.
-
Montagu Acquires Majority Stake in HTL Biotechnology
February 28, 2022
Pharmaceuticals
Montagu, a leading private equity firm, has acquired a majority stake in HTL (HTL Biotechnology) from Bridgepoint, with minority shareholders Naxicap and Téthys Invest retaining their holdings. Montagu will support HTL's international expansion, R&D and premium product positioning and has appointed Paul Navarre as Chairman to help drive the company's next growth phase.
-
Groupe Berkem Acquires i.Bioceuticals from International Nutrition Company (INC)
February 16, 2023
Food & Beverage
Groupe Berkem has acquired i.Bioceuticals, the exclusive North American distributor of OPC and pine bark extracts from Dutch supplier International Nutrition Company (INC). The cash transaction transfers i.Bioceuticals' Massachusetts-based team to Groupe Berkem as the Group expands its bio-based health, beauty and nutraceutical offering and strengthens its footprint in North America.
-
Miura Partners Acquires HTBA (HealthTech BioActives)
November 5, 2024
Biotechnology
Miura Partners has signed an agreement to acquire HTBA (HealthTech BioActives), a Barcelona-headquartered producer of flavonoids and active vitamin B12 used across pharmaceutical, nutraceutical, food & beverage and animal nutrition markets. Miura will pursue organic and inorganic initiatives to consolidate HTBA as a leading platform for natural ingredients; the deal is the third investment from Miura Fund IV and is pending approval from the Spanish regulator.
-
NewCo Plastics Acquires Majority Stake in Hilco Technologies
July 16, 2021
Manufacturing
NewCo Plastics, a holding company formed by White Wolf Capital, has acquired a majority stake in Hilco Technologies, a Grand Rapids-based plastics manufacturer. Hilco provides thermoplastic and gas-assist injection molding, abrasion-resistant hard-coating, and rapid prototyping services to medical, automotive and other industrial end markets; financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.